Overall survival in patients with advanced non-small cell lung cancer with KRAS G12C mutation with or without STK11 and/or KEAP1 mutations in a real-world setting

por Julian, Cristina, Pal, Navdeep, Gershon, Anda, Evangelista, Marie, Purkey, Hans, Lambert, Peter, Shi, Zhen, Zhang, Qing
Publicado 2023

Real‐world data prognostic model of overall survival in patients with advanced NSCLC receiving anti‐PD‐1/PD‐L1 immune checkpoint inhibitors as second‐line monotherapy

por Julian, Cristina, Machado, Robson J. M., Girish, Sandhya, Chanu, Pascal, Heinzmann, Dominik, Harbron, Chris, Gershon, Anda, Pfeiffer, Shannon M., Zou, Wei, Quarmby, Valerie, Zhang, Qing, Chen, Yachi
Publicado 2022

Venetoclax and Hypomethylating Agents as First-line Treatment in Newly Diagnosed Patients with AML in a Predominately Community Setting in the US

por Vachhani, Pankit, Flahavan, Evelyn M, Xu, Tao, Ma, Esprit, Montez, Melissa, Gershon, Anda, Onishi, Maika, Jin, Huan, Ku, Grace, Flores, Brannon, Bui, Cat N, Abbas, Jonathan A, Donnellan, William
Publicado 2022